Form 4: Lenz Therapeutics Director Acquires Stock Options Following Merger

Frederic Guerard, a director of Lenz Therapeutics, acquired stock options as a result of the merger with LENZ Therapeutics Operations, Inc.

Summary

• Frederic Guerard, a director of Lenz Therapeutics, acquired stock options on March 21, 2024, following the merger with LENZ Therapeutics Operations, Inc.
• The options were granted in exchange for outstanding options to purchase shares of LENZ OpCo, pursuant to the terms and conditions of the Merger Agreement dated November 14, 2023.
• Guerard acquired options to purchase 30,897 shares at $2.08, 23,571 shares at $6.04 and 27,000 shares at $15.05.
• The options vest over time, contingent on Guerard's continued service to the company.
• The vesting schedules vary for each option grant, with vesting commencement dates of September 17, 2021, March 6, 2023, and March 21, 2024.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options is a common practice and suggests confidence in the company's future, but the value is contingent on future performance.

Positives

• The acquisition of stock options by a director aligns their interests with those of the shareholders.
• The vesting schedules incentivize continued service and commitment to the company's success.

Risks

• The value of the stock options is dependent on the future performance of Lenz Therapeutics.
• If Guerard ceases to be a service provider, the unvested options will be forfeited.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the stock options.

Industry Context

Stock option grants to directors are a common practice in the pharmaceutical industry to incentivize performance and align interests with shareholders, especially following a merger.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech industry.
• Companies like Alcon and Bausch + Lomb also use stock options to incentivize their leadership teams.
• The vesting schedules and exercise prices are generally in line with industry norms for similar-stage companies.

Stakeholder Impact

• Shareholders may view the stock option grants positively as they align the director's interests with the company's success.
• Employees may be motivated by the fact that leadership is incentivized to improve company performance.

Key Dates